HPI in Laparoscopic Colorectal Surgery
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Dec 25, 2024
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the use of a tool called the Hypotension Prediction Index (HPI) during laparoscopic colorectal surgery, which is a type of surgery done with small cuts to reduce recovery time. The goal is to see if this tool can help predict and manage low blood pressure (hypotension) that can happen during surgery, which is important for keeping patients safe.
To participate in this trial, patients must be scheduled for elective laparoscopic colorectal surgery and be between the ages of 7304 and older. Those with severe heart or lung diseases cannot join. If you decide to participate, you will be monitored closely during your surgery to see how well the HPI works in helping to manage your blood pressure. This trial is currently recruiting participants at two hospitals in Taiwan and aims to improve surgical care for patients like you.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients undergoing elective laparoscopic colorectal surgery
- Exclusion Criteria:
- • Severe heart or lung diseases
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported